Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.

Citation:
MA, A., M. TA, M. KA, and M. HA, "Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.", Ophthalmic Res, vol. 45, issue 1, pp. 23-30, 2011.

Notes:

n/a

PreviewAttachmentSize
CU-PDF21.99 KB
Tourism